Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Who We Help
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Who We Help
Who We Help/
WHO WE HELP
  • Pharmaceutical Manufacturers
  • Emerging Biopharma
  • MedTech
  • Financial Institutions
  • Government and Public Health
  • Health Plans
  • Hospital and Health Systems
  • Insurers and Risk
  • Medical Specialty and Patient Advocacy
Pharmaceutical Manufacturers

Harness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.

Harness Data
Pharmaceutical Manufacturers
Emerging Biopharma (Global page)

Boost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.

Discover Innovations
MedTech

Navigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.

Explore MedTech
MedTech
Financial Institutions

Invest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.

Access Insights
Government and Public Health

Unlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.

Unlock Innovations
Government and Public Health
Health Plans

Accelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.

Navigate Health Plans
Hospital and Health Systems

Leverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.

Streamline Decisions
Hospital and Health Systems
Insurers and Risk

Enhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.

Evaluate Risk
Medical Specialty and Patient Advocacy

Transform into a data-driven organization that enhances your specialty and showcases value to your members through digital transformation.

Enhance Your Specialty
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS

PODCASTS

"Discover the future through our enlightening podcasts available in the United States.

EXPLORE PODCASTS

FACT SHEET

"IQVIA AI Medical Record Review

LEARN MORE

BLOG

"Decoding DSCSA: Ensuring Compliance in the Pharmaceutical Supply Chain

READ MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

WATCH ON-DEMAND WEBINARS
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

DISCOVER EVENTS & WEBINARS

EVENT

"26th Controlled Substances and State Regulatory Conference

REGISTER NOW
MAIN/Contact Us
Contact Us/
Blog
Patients, Payers, Policy & Pressure: Trends to Watch in 2021
Luke Greenwalt, Vice President, IQVIA Market Access Center of Excellence
Jul 13, 2021

It has become increasingly difficult to forecast and achieve net sales goals. Pressures were building long before 2020, and the COVID-19 pandemic has only accelerated and amplified the challenges.

Net pricing has been below the Consumer Price Index (CPI) since 2015 — years before the pandemic. Manufacturer net discounts, a primary driver, continue to climb and now average 54% for traditional and 41% for specialty treatments. When added to the pricing picture, those discounts often push net prices below the rate of inflation or even negative in some instances.

Meanwhile, an estimated one billion anticipated diagnosis visits to healthcare providers simply did not happen last year due to the impact of the COVID-19 pandemic. That translates into an unexpected decline of 30% -- a gap that hit oncology, gastroenterology, dermatology, anesthesiology, and ophthalmology the hardest.

Other demand and margin factors are also at play. On the demand side of the equation, challenges include restrictive formulary designs, higher patient co-pays and deductibles, declining patient value, and an overall erosion in promotional effectiveness. When it comes to margin, challenges include contracting pressures and higher rebates, higher costs associated with offsetting patient co-pays, changing (and uncertain) public policy design, and leakage related to the 340B Drug Pricing Program.

Add it up and you have what IQVIA calls “The Big Squeeze.”

In the face of these pressures, brand teams are challenged to determine the right level and type of investment in market access, patient services, and elsewhere. Making the best possible decisions requires an understanding of multiple interrelated factors and the ability to tackle these questions:

  • How does pricing strategy impact gross sales?
  • When it comes to rebates, how much should you contract for? How do you run operations?
  • What can you do to mitigate the explosive growth of the 340B Drug Pricing Program?
  • How does patient co-pay impact demand and margin?
  • In the realm of Medicaid and Medicare, how might healthcare policy affect patient access, eligibility, and benefit design?

When old rules and assumptions no longer apply, there are no quick or easy answers to those critical questions. But in this blog series, we will take a closer look at some key trends that should help inform your answers as we continue making our way into the post-pandemic reality. My next post will highlight the role of increasing payer controls – including step edits and National Drug Code (NDC) blocks – and address how payer controls impact market sizing assumptions.

Battling the Big Squeeze

Globally and within the US, IQVIA is well positioned to help clients strategically identify how, where, why, and when challenges in demand and margin will impact business, operations, and strategic decision-making.

Learn more
SUBSCRIBE
IQVIA Blog Digest
For all the latest industry insights, please subscribe to the IQVIA U.S. blog digest.
SUBSCRIBE
Contact Us